本页面由Tiger Trade Technology Pte. Ltd.提供服务

神经分泌生物科学

135.13
-6.2400-4.41%
盘后:135.950.8200+0.61%16:35 EDT
成交量:156.21万
成交额:2.12亿
市值:137.83亿
市盈率:19.81
高:139.93
开:139.60
低:134.89
收:141.37
52周最高:186.12
52周最低:122.14
股本:1.02亿
流通股本:9,999.56万
量比:1.31
换手率:1.56%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
净资产收益率:22.09%
总资产收益率:11.70%
市净率:3.73
市盈率(LYR):28.94

数据加载中...

2021/10/06

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/03

重要事件披露

8-K - Current report
2021/05/21

重要事件披露

8-K - Current report
2021/05/05

重要事件披露

8-K - Current report
2021/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/16

重要事件披露

8-K - Current report
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/04

重要事件披露

8-K - Current report
2021/02/02

重要事件披露

8-K - Current report
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals